PRW Wealth Management’s DexCom DXCM Stock Holding History

PRW Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-332	Closed	-$10K	–	233
2019 Q1	$10K	Hold	332	–	–	0.01%	283
2018 Q4	$10K	Buy	+332	New	+$10.5K	0.01%	286

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

PRW Wealth Management's DXCM Position: Q2 2019 in Review

PRW Wealth Management sold out of DexCom (DXCM) in Q2 2019, closing a stake of 332 shares — an estimated $10K sold.

PRW Wealth Management first reported a position in DXCM in Q4 2018 and held it in 2 quarters. The position peaked at $10K in Q1 2019. 418 funds tracked by Wall St. Rank hold DXCM as of Q2 2019.

PRW Wealth Management reported no remaining DexCom position as of Q2 2019 after selling out during the quarter.
PRW Wealth Management sold 332 DexCom shares in Q2 2019, an estimated $10K.
PRW Wealth Management first reported a position in DexCom in Q4 2018 and held it in 2 quarters.
PRW Wealth Management's DexCom position peaked at $10K in Q1 2019.
418 funds tracked by Wall St. Rank held DexCom as of Q2 2019.

Based on PRW Wealth Management's 13F filing for Q2 2019, filed 12 Aug 2019.